<SUBMISSION>
<ACCESSION-NUMBER>0000930413-08-001085
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20080213
<ITEMS>8.01
<ITEMS>9.01
<FILING-DATE>20080219
<DATE-OF-FILING-DATE-CHANGE>20080219
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>Assured Pharmacy, Inc.
<CIK>0001100592
<ASSIGNED-SIC>5912
<IRS-NUMBER>980233878
<STATE-OF-INCORPORATION>NV
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-33165
<FILM-NUMBER>08625462
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>17935 SKY PARK CIRCLE
<STREET2>SUITE F
<CITY>IRVINE
<STATE>CA
<ZIP>92614
<PHONE>949-222-9971
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>17935 SKY PARK CIRCLE
<STREET2>SUITE F
<CITY>IRVINE
<STATE>CA
<ZIP>92614
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>ERXSYS INC
<DATE-CHANGED>20030916
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>SURFORAMA COM INC
<DATE-CHANGED>20001128
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c52391_8k.htm
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">


<P align="center">
<FONT face="serif">UNITED STATES </FONT><BR>
<FONT face="serif">SECURITIES AND EXCHANGE COMMISSION </FONT><BR>
<FONT face="serif">WASHINGTON, D.C. 20549 </FONT><BR>
<BR>
<FONT face="serif">FORM 8-K</FONT><BR>
<FONT face="serif">CURRENT REPORT </FONT><BR>
<FONT face="serif">PURSUANT TO SECTION 13 OR 15(D) </FONT><BR>
<FONT face="serif">OF THE SECURITIES EXCHANGE ACT OF 1934</FONT></P>
<P align="center">
<FONT face="serif">February 13, 2008 </FONT><BR>
<FONT face="serif">--------------------------- </FONT><BR>
<FONT face="serif">Date of Report (Date of earliest event reported)</FONT><BR>
<BR>
<FONT face="serif">ASSURED PHARMACY, INC. </FONT><BR>
<FONT face="serif">----------------------------------------------- </FONT><BR>
<FONT size=2 face="serif">(Exact name of registrant as specified in its charter)</FONT></P>
<TABLE border=0 width=100% cellspacing=0 cellpadding=0>
<TR>
     <TD width=36%></TD>
     <TD width=2%></TD>
     <TD width=32%></TD>
     <TD width=2%></TD>
     <TD width=26%></TD></TR>
<TR valign="bottom">
	<TD align=center nowrap>
<FONT face="serif">Nevada</FONT>	</TD>
	<TD>&nbsp;	</TD>
	<TD align=center nowrap>
<FONT face="serif">000-33165</FONT>	</TD>
	<TD>&nbsp;	</TD>
	<TD align=left nowrap>
 &nbsp;
 <div align="center"><FONT face="serif">98-0233878</FONT> </div></TD>
</TR>
<TR valign="bottom">
	<TD align=center nowrap>
<FONT face="serif">------------</FONT>	</TD>
	<TD>&nbsp;	</TD>
	<TD align=center nowrap>
<FONT face="serif">-------------</FONT>	</TD>
	<TD>&nbsp;	</TD>
	<TD align=left nowrap><div align="center"><FONT face="serif">--------------</FONT> </div></TD>
</TR>
<TR valign="bottom">
	<TD align=center nowrap>
<FONT size=2 face="serif">(State or other jurisdiction</FONT>	</TD>
	<TD>&nbsp;	</TD>
	<TD align=center nowrap>
<FONT size=2 face="serif">(Commission</FONT>	</TD>
	<TD>&nbsp;	</TD>
	<TD align=center nowrap>
      <div align="center"><FONT size=2 face="serif">(IRS Employer</FONT>      </div></TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">of incorporation)</FONT>	</TD>
	<TD>&nbsp;	</TD>
	<TD align=center nowrap>
<FONT size=2 face="serif">File Number)</FONT>	</TD>
	<TD>&nbsp;	</TD>
	<TD align=left nowrap>
      <div align="center"><FONT size=2 face="serif">Identification No.)</FONT>      </div></TD>
</TR>
</TABLE>
<BR>
<P align="center">
<FONT face="serif">17935 Sky Park Circle, Suite F, Irvine, CA, 85016 </FONT><BR>
<FONT face="serif">---------------------------------------------------------------</FONT><BR>
<FONT size=2 face="serif">(Address of principal executive offices) </FONT><BR>
<BR>
<FONT size=2 face="serif">(949) 222-9971 </FONT><BR>
<FONT size=2 face="serif">--------------------- </FONT><BR>
<FONT size=2 face="serif">(Registrant&#146;s telephone number, including area code)</FONT></P>
<div style="border-top:1px solid #000000">
  <div align="center"><font size=2 face="serif">(Former
    name or former address, if changed since last report.) </font> </div>
</div>
<P align="center">&nbsp;</P>
<P align="justify">
<FONT size=2 face="serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: <br>
<br>
[&nbsp;&nbsp; ] Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425) <br>
<br>
[&nbsp;&nbsp; ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a -12) <br>
<br>
[&nbsp;&nbsp; ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))<br>
<br>
[&nbsp;&nbsp; ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c)) </FONT></P>

<HR noshade align="center" width="100%" size=4>



<P align="left" style="page-break-before:always"></P><PAGE>
<P align="justify">
<B><FONT face="serif">Item 8.01  &nbsp;&nbsp;&nbsp;Other Events</FONT></B></P>
<P align="justify">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="serif"> On February 13, 2008, the Registrant issued a press release announcing that it has consolidated the operation of its pharmacy located at 3822 S.E. Powell Blvd. in Portland, Oregon, which was opened under previous management, into
the Registrant&#146;s 10196 SW Park Way pharmacy, also in Portland. The consolidation will allow the Registrant to further leverage its existing infrastructure and is expected to result in a reduction of costs. A copy of the press release is
attached hereto as exhibit 99.1. </FONT></P>
<P align="justify">
<B><FONT face="serif">Item 9.01  &nbsp;&nbsp;&nbsp;Financial Statements and Exhibits </FONT></B></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR>
  <TD width="3%" valign=top nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
	<TD width="3%" valign=top nowrap>
<FONT face="serif">a)</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD width=94%>
<P align="justify"><FONT face="serif">Not applicable.</FONT></P>	</TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR><TR>
  <TD nowrap valign=top>&nbsp;</TD>
	<TD nowrap valign=top>
<FONT face="serif">b)</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<P align="justify"><FONT face="serif">Not applicable.</FONT></P>	</TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR><TR>
  <TD nowrap valign=top>&nbsp;</TD>
	<TD nowrap valign=top>
<FONT face="serif">c)</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<P align="justify"><FONT face="serif">Exhibits</FONT></P>	</TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR><TR>
  <TD>&nbsp;</TD>
<TD>&nbsp;</TD>	<TD>
<P align="justify"><FONT face="serif">99.1. Press Release, dated February 13, 2008</FONT></P>
	</TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR></TABLE>

<HR noshade align="center" width="100%" size=4>



<P align="left" style="page-break-before:always"></P><PAGE>
<P align="center">
<FONT face="serif">SIGNATURE</FONT></P>
<P align="justify">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<TABLE border=0 width=100% cellspacing=0 cellpadding=0>
<TR>
     <TD width=41%></TD>
     <TD width=3%></TD>
     <TD width=5%></TD>
     <TD width=51%></TD></TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT face="serif">Dated: February 15, 2008</FONT>	</TD>
	<TD>&nbsp;	</TD>
	<TD align=left nowrap>&nbsp;	</TD>
	<TD align=left nowrap>&nbsp;	</TD>
</TR>
<TR>
	<TD colspan=4>&nbsp;	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>&nbsp;	</TD>
	<TD>&nbsp;	</TD>
	<TD align=left nowrap colspan=2>
<FONT face="serif">ASSURED PHARMACY, INC.</FONT>	</TD>
</TR>
<TR>
	<TD colspan=4>&nbsp;	</TD>
</TR>
<TR>
	<TD colspan=4>&nbsp;	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>&nbsp;	</TD>
	<TD>&nbsp;	</TD>
	<TD align=left nowrap>
<FONT face="serif">By:</FONT>	</TD>
	<TD align=left nowrap style="border-bottom:1px solid #000000;">/s/ Robert DelVecchio</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>&nbsp;	</TD>
	<TD>&nbsp;	</TD>
	<TD align=left nowrap>
<FONT face="serif">Name:</FONT>	</TD>
	<TD align=left nowrap>
<FONT face="serif">Robert DelVecchio</FONT>	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>&nbsp;	</TD>
	<TD>&nbsp;	</TD>
	<TD align=left nowrap>
<FONT face="serif">Title:</FONT>	</TD>
	<TD align=left nowrap>
<FONT face="serif">Chief Executive Officer</FONT>	</TD>
</TR>
</TABLE>
<BR>

<HR noshade align="center" width="100%" size=4>


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>c52391_ex99-1.htm
<TEXT>

<HTML>
<HEAD>
   <TITLE>c52391_ex99-1.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">




<P align="right">
<FONT face="serif">Exhibit 99.1</FONT></P>
<P align="center">
<B><U><FONT size=2 face="serif">Assured Pharmacy Consolidates Portland, Oregon Pharmacy</FONT></U></B></P>
<P align="justify">
<FONT size=2 face="serif">IRVINE, California &#150; 2/13/08 -- Assured Pharmacy, Inc. (OTCBB: APHY) today announced it has consolidated the operation of its pharmacy located at 3822 S.E. Powell Blvd in Portland, Oregon. This pharmacy was opened
under previous management, and is being consolidated into Assureds&#146; 10196 SW Park Way pharmacy, which is also located in Portland. Consolidating the Powell Blvd pharmacy allows Assured to further leverage its existing infrastructure and is
expected to result in reduced costs. Assured Pharmacy, Inc. is a specialty pharmacy providing customized services for individuals with and physicians treating chronic pain. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">All remaining pharmacies, including the 3 inherited by current management, are well-situated, and on track to ultimately reach the annual revenue target of &#36;5 million per pharmacy. The Powell Blvd location, while cash
flow positive on an operating basis, does not have the appropriate demographics to meet current management&#146;s annual revenue target.</FONT></P>
<P align="justify">
<FONT size=2 face="serif">Assured&#146;s current management team seeks to locate pharmacies in areas where there are large numbers of targeted physicians in the vicinity of any prospective location. Assured is focused on obtaining its customers
directly in a physicians&#146; office, creating a superior due diligence process, and affording Assured an important advantage in the marketplace for dispensing chronic pain medications. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">&#147;Having inherited 2 of our 3 Oregon locations, closing
the Powell Blvd location appropriately restructures our presence in the Portland
market. We are exploring other potential locations in the Oregon area, as well
as in  other states. At this early stage in our growth, we believe we are able
to cherry pick the best opportunities for our new pharmacy locations. The strength
of our business model is in the financial metrics. We remain committed to growing
and  developing retail pharmacies in locations in which our careful due diligence
indicates significant demand for our services,&#148; stated Mr. Robert DelVecchio,
CEO of Assured Pharmacy. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Assured Pharmacy provides customized services for individuals with and physicians treating chronic pain. These services consist of specialized expertise in dispensing pain medication, including DEA-classified Schedule II
substances, streamlined prescription processes, digital prescribing technologies, and specialty drug compounding services. Assured Pharmacy also offers a complete line of durable medical equipment through its DME division. Assured Pharmacy currently
operates six retail sites: two in California (Santa Ana and Riverside), one in Las Vegas, Nevada, two in Portland, Oregon and one in Kirkland, Washington. More information about Assured Pharmacy is available at </FONT><FONT size=2 face="serif">http://www.assuredpharmacy.com</FONT><FONT color="#0000ff" size=2 face="serif">.</FONT></P>
<P align="justify">
<B><U><FONT size=2 face="serif">Contact:</FONT></U></B><B><FONT size=2 face="serif"> </FONT></B><BR>
<FONT size=2 face="serif">John Tsemberides</FONT><BR>
<FONT size=2 face="serif">ROI Group LLC </FONT><BR>
<FONT size=2 face="serif">212.495.0743 </FONT><BR>
<FONT size=2 face="serif">john@roiny.com</FONT><FONT size=2 face="serif"> </FONT></P>
<P align="center">
<FONT size=2 face="serif">#</FONT><FONT size=2 face="serif">&#160;</FONT><FONT size=2 face="serif">#</FONT><FONT size=2 face="serif">&#160;</FONT><FONT size=2 face="serif">#</FONT><FONT size=2 face="serif">&#160;</FONT></P>
<P align="justify">
<I><FONT size=2 face="serif">Certain statements in this news release may constitute "forward-looking" statements within the meaning of section 21E of the Securities and Exchange Act of 1934. The Company believes that its
expectations, as expressed in these statements are based on reasonable assumptions regarding the risks and uncertainties inherent in achieving those expectations. These statements are not, however, guarantees of future performance and actual results
may differ materially. Some of the factors that may affect the forward-looking statements in this news release are the availability of licensed personnel to operate pharmacies, the availability of suitable pharmacy locations, and the acceptance of
new technologies by the medical profession. Other risk factors are listed in the most recent Annual Report on Form 10-KSB, Quarterly Report on Form 10-QSB, and most recent Registration Statement on Form SB-2 filed with the Securities and Exchange
Commission. Such forward-looking statements involve risks, uncertainties, which may cause the actual results, performance, or achievement expressed or implied to differ. </FONT></I></P>

<HR noshade align="center" width="100%" size=4>


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
</SUBMISSION>
